Back to Search
Start Over
Novel heterozygous VPS13A pathogenic variants in chorea-neuroacanthocytosis: a case report.
- Source :
-
BMC neurology [BMC Neurol] 2023 Oct 04; Vol. 23 (1), pp. 350. Date of Electronic Publication: 2023 Oct 04. - Publication Year :
- 2023
-
Abstract
- Background: Chorea-acanthocytosis (ChAc) is a rare hereditary autosomal recessive neurodegenerative disorder caused by pathogenic variants of the Vacuolar Protein Sorting 13 homolog A (VPS13A) gene. The variant spectrum of VPS13A has not been completely elucidated. This study reports two novel heterozygous VPS13A pathogenic variants in ChAc that expand the variant spectrum of VPS13A.<br />Case Presentation: We described a case of a 29-year-old man with typical clinical manifestations of ChAc, including chorea, orofacial lingual dyskinesia, vocal tics, elevated serum biochemical indicators, increased acanthocytes in peripheral blood, and caudate nucleus atrophy. Next-generation sequencing revealed two heterozygous variants of VPS13A: a nonsense variant (NM&#95;033305.2: c.8215G > T, p. Glu2739Ter) and a deletion variant in the exons 25-31.<br />Conclusion: The identified nonsense variant gives rise to premature translation termination, while the deletion variant is expected to cause a significant in-frame deletion of amino acid residues in the encoded protein. Both variants are considered to be pathogenic and result in loss-of-function proteins. These findings have implications for the genetic counseling of patients with VPS13A variants.<br /> (© 2023. BioMed Central Ltd., part of Springer Nature.)
Details
- Language :
- English
- ISSN :
- 1471-2377
- Volume :
- 23
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- BMC neurology
- Publication Type :
- Academic Journal
- Accession number :
- 37794323
- Full Text :
- https://doi.org/10.1186/s12883-023-03398-x